Clinical Trials

MainTitle

Depot Disulfiram for AIDS and ARC

This study has been completed
Sponsor
St. Vincent's Medical Center


Information provided by (Responsible Party)
NIH AIDS Clinical Trials Information Service
ClinicalTrials.gov Identifier
NCT00002065

First received: November 2, 1999
Last updated: June 23, 2005
Last Verified: November 1999
History of Changes
Purpose

Purpose

To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.

Condition Intervention
HIV Infections

Drug : Disulfiram

Study Type: Interventional
Study Design: Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Depot Disulfiram for AIDS and ARC

Further study details as provided by NIH AIDS Clinical Trials Information Service:

Eligibility

Eligibility

Ages Eligible for Study: 18 Years and older  
Sexes Eligible for Study: All  
Accepts Healthy Volunteers: No  

Criteria

Inclusion Criteria
Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.

  • Also patient must be:
  • Able to understand the study.
  • Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
  • Ambulatory and able to maintain an independent life outside the hospital.
  • Free of clinically significant organic disease affecting neurologic, hepatic, renal,
and clinical status.
Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
History of alcohol abuse.

contacts and locations

Contacts and Locations

Choosing to participate in a study is an important personal decision.Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002065

Locations

United States, New York
Saint Vincent's Med Ctr
Staten Island, New York, United States, 10310

Sponsors and Collaborators

St. Vincent's Medical Center
More Information

More Information


Responsible Party: St. Vincent's Medical Center  
ClinicalTrials.gov Identifier: NCT00002065   History of Changes  
Other Study ID Numbers: 024A  
Study First Received: November 2, 1999  
Last Updated: June 23, 2005  

Keywords provided by NIH AIDS Clinical Trials Information Service:

Delayed-Action Preparations
Disulfiram
Acquired Immunodeficiency Syndrome
AIDS-Related Complex

Additional relevant MeSH terms:
HIV Infections
Disulfiram

ClinicalTrials.gov processed this data on December 15, 2017
This information is provided by ClinicalTrials.gov.